Canada issues warning over glucose monitors:
This article was originally published in Clinica
Executive Summary
Patients with kidney failure who use Baxter's peritoneal dialysis solution containing icodextrin (Extraneal) should ensure that they use glucose monitors not subject to interference from sugars that are released by the icodextrin. The result of using the wrong type of monitor is a falsely elevated glucose monitor reading, which can also mask a consequent hypoglycaemic effect, which could result in coma if, due to being masked, it is left untreated. Health Canada has advised patients who use icodextrin-containing dialysis solution to wear some form of personal identification, such as the bracelets and pendants available from MedicAlert, to help avoid the danger.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.